How a New Twice-Yearly Drug Is Prompting Hopes of Curbing HIV Cases

New twice-yearly drug prompting hopes of curbing HIV cases

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not only offers nearly 100 percent protection from HIV, but people only need two injections per year. William Brangham discussed more with Mitchell Warren of the AIDS Vaccine Advocacy Coalition.

How a new twice-yearly drug is prompting hopes of curbing HIV cases

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not only offers nearly 100 percent protection from HIV, but people only need two injections per year. William Brangham discussed more with Mitchell Warren of the AIDS Vaccine Advocacy Coalition.

PrEP Side Effects: Separating Fact from Fiction

Credit: Unsplash All medicines have side effects – HIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally very safe. Major health authorities report “PrEP is safe” and have found no significant health problems even after five years of use, HIV.gov reports. When taken every day as prescribed, PrEP reduces your chance of getting HIV from sex by about 99% (and by at least 74% for…

TWICE-A-YEAR SHOT COULD TRANSFORM HIV PREVENTION, BUT CAN THE WORLD AFFORD IT?

Tue 01 July 2025: Around 40 million people across the world are currently living with HIV, a virus that has claimed more than 42 million lives since the beginning of the epidemic. But for the first time in decades, scientists and public health officials are daring to talk about a realistic path to ending HIV […]